Dendreon's Unattributed VC Round

Dendreon raised a round of funding on July 24, 1998.

Dendreon is a biopharmaceutical company targeting cancer through the discovery, development, commercialization, and manufacturing of novel therapeutics. Its product Provenge is an autologous cellular …

Articles about Dendreon's Unattributed VC Round: